Andrew Joy

Andrew Joy

Senior Advisor

London, GB

Profile Verified by The Marque

Last Updated: 22 Sep 2026

In Their Own Right

Biography

Andrew Joy joined Stonehage Fleming as a Senior Advisor in 2013. He also Chairs Stonehage's Private Equity Investment Committee.

Andrew’s career has been in private equity, and he is a former Chairman of the British Venture Capital Association and a Director of its European equivalent, the EVCA.

He is Chairman of the Investment Committee at FPE Capital, a private equity fund investing in UK growth companies. Andrew is also Chairman of Herald Investment Trust plc, a company that invests in smaller quoted companies globally in the TMT sector. Until July 2022, Andrew served as Chairman of The Biotech Growth Trust plc, a company that invests in publicly listed biotech companies, mostly based in the US.

He spent 21 years as a Senior Partner at Cinven, the leading private equity partnership he co-founded in 1992, and served as chairman or director of many of the companies in which Cinven invested.

Andrew’s other roles include serving as a Trustee of Centre for Entrepreneurs; as a Member of the Council of Fauna and Flora International (FFI), the longest-established wildlife conservation charity in the world; and, until August 2023, as a Fellow and Chairman of the Investment Committee of Winchester College.

He is a graduate of New College, University of Oxford.

The Record

Background

  • 2013 — Present

    Senior Advisor

    Corient (Formerly: Stonehage Fleming)

    Stonehage Fleming is the largest multi-family office in Europe, serving individuals and families seeking fiduciary, asset management and other services. Andrew is a Senior Advisor and Chairman of the Private Equity Investment Committee.

  • 1992 — 2016

    Founding Partner & Senior Advisor

    Cinven

    Cinven is a leading private equity firm with some €15bn under management, and offices across Europe, in Hong Kong and in New York. Within its chosen sectors Cinven buys companies capable of strong growth and helps them achieve that growth through management initiatives and international expansion. Cinven has approximately 200 institutional investors.

Formative Years

Education

  • University of Oxford

    PPE (MA), First

    1975 — 1978

Areas Of Focus

Expertise

  • Private Equity
  • Technology
  • Philanthropy
  • Family Office
  • Venture Capital
  • Advisory
  • Asset Management
  • Biotechnology
  • Charity/Foundation Governance
  • Investment Banking
  • Investment Management